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staging must be performed in cases considered for surgical treatment 
even when positive mediastinal lymph nodes are detected in PET-CT. 
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Background: Nodular lymphoid hyperplasia (NLH) is one of the rare 
pulmonary lymphoproliferative disorders which may appear as a soli-
tary or multiple lesions. 
Method: A 61-year-old immunocompetent patient was admitted to our 
hospital with cough and hemoptysis. He was a heavy smoker without a 
history of tuberculosis. Physical examination was unremarkable. Chest 
X-ray demonstrated a mass located in the right middle zone. Thorax 
CT revealed a cavitary pulmonary mass (3x6 cm) and a satellite nodule 
localized to the superior segment of right lower lobe. In further evalu-
ation of the patient with bronchoscopy, endobronchial lesion could not 
be detected. The histopathological assessment of bronchoalveolar la-
vage, brush and aspiration ﬂuid were benign, and the smear was nega-
tive for tuberculosis. A second bronchoscopy to reach the diagnosis was 
uneventful and transthoracic needle aspiration revealed lymphocytes 
and leucocytes without an evidence of malignancy. Anti-tuberculosis 
therapy was initiated although the smear was negative for tuberculosis 
due to the high incidence of tuberculosis in our country. Four months 
later, he was referred from the local tuberculosis dispensary to our 
clinic with massive hemoptysis. Thorax CT showed that there was not 
any change of the lesion. Anti-tuberculosis therapy was stopped for 
the cultures for sputum and bronchoscopic materials were negative. 
Vasculitic syndromes, ie. Wegener’s granulomatosis were suspected 
in the presence of unidentiﬁed cavitary lesions. Myeloperoxidase and 
antiproteinase ANCA were negative. 
Result: FDG-PET standard uptake value was positive (SUV: 4.1), 
indicating malignancy. There was not any pathological FDG uptake 
in the other parts of the body. An open lung biopsy revealed the ﬁnal 
diagnosis of NLH, of which the histologic examination was positive for 
CD3, CD20 and LCA and negative for keratin. 
Conclusion: nodular lymphoid hyperplasia should be kept in mind 
in the differential diagnosis of the cavitary mass lesions with positive 
FDG uptake.
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Background: To correlate FDG uptake on PET/CT images with the 
expression of Glut-1 and Glut-3 glucose transporters in patients with 
non-small cell lung cancer (NSCLC).
Methods: Preoperative 18F-FDG PET/CT images were performed 
in 68 patients with non-small cell lung cancer. Final diagnoses were 
conﬁrmed by operative histology (37 adenocarcinoma, 28 squamous 
cell carcinoma, 2 large cell carcinoma and 1 pleomorphic carcinoma). 
The peak standardized uptake value (pSUV) of the lung cancer FDG 
uptake was measured and correlated to immunohistochemistry results 
for Glut-1 and Glut-3. In the immunohistochemical studies, (1) the in-
tensity of the immunoreactivity (grade 0 to3) and (2) percentage of the 
area testing positive (<25%; 26~50%; 51%~75%; <100%) for Glut-1 
and Glut-3 were reviewed. 
Results: The mean pSUV was 9.26±3.85 in squamous cell carcinoma, 
and 6.03±4.20 in adenocarcinoma. Intense FDG uptake of pSUV above 
8.0 was seen in 2 large cell carcinoma and one pleomorphic carcinoma 
cases. Squamous cell carcinoma had signiﬁcantly higher mean pSUV 
than adenocarcinoma (p=0.002). The expression of Glut-1 was also sig-
niﬁcantly higher in squamous cell carcinoma than in adenocarcinoma 
for both the grade of intensity (p=0.000) and the percentage of positive 
area (p=0.000), whereas the expression of Glut-3 was not signiﬁcantly 
different between adenocarcinoma and squamous cell carcinoma. The 
degree of pSUVs demonstrated signiﬁcant correlation with the intensity 
(p=0.000) and percentage of positive area of Glut-1 (p=0.003), and 
with the intensity of Glut-3 (p=0.002). However, the percentage of 
Glut-3 positive area and pSUV had no signiﬁcant correlation (p=0.064).
Conclusions: This study indicates that squamous cell carcinomas have 
higher FDG uptake and Glut-1 expression than adenocarcinomas. The 
FDG uptake in NSCLC correlates with the intensity and percentage 
of positive area of Glut-1, and intensity of Glut-3, but not with the 
percentage of Glut-3 positive area.
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Background: TO compare the clinical value of computed tomography 
(CT) and ﬂuorine-18 ﬂuorodeoxyglucose positron remission tomog-
raphy (FDG-PET) in diagnosis of mediastinal metastasis of non-small 
cell lung cancer (NSCLC).
Methods: From 2004 to 2006 75 patients with respectable NSCLC un-
derwent CT and FDG-PET with an interval of 2 weeks and then under-
went thoracotomy for clearance of mediastinal lymph nodes or biopsy 
of the mediastinal lymph nodes via mediastinoscopy. The specimens 
of mediastinal lymph nodes underwent HE staining and PCNA/Ki67 
immunohistochemical staining.The sensitivity, speciﬁcity, accuracy, 
positive prediction value, and negative prediction value in diagnosis 
of metastasis of mediastinal lymph nodes of these 2 procedures were 
compared. 
Results: The sensitivity, speciﬁcity, accuracy, positive prediction value, 
and negative prediction value in diagnosis of metastasis of mediastinal 
lymph nodes were 91.2%, 85.5%, 94.2%, 93.1%, 73.1% respectively 
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for FDG-PET, and were 81.3%, 55.1%, 72.4%, 84.1%, 41.5% respec-
tively for CT. The sensitivity rate was 98% for CT plus FDG-PET. 
Conclusion: PET is superior to CT in diagnosis of metastasis of 
MSCLC to mediastinal lymph nodes. PET+CT signiﬁcantly increases 
the sensitivity in diagnosi Non-small cell lung cancer; Radioactive trac-
ers; Tomography, emission-computed; Lymph nodes, mediastinal 
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Background: Lung cancer is the leading cause of cancer death 
worldwide and determining involvement of the mediastinum is of vital 
importance to determine the prognosis and treatment plan. There are 
many mediastinal staging modalities, however, transbronchial needle 
aspirations (TBNA) is an optimal invasive procedure that remains un-
derutilized. Several explanations have been suggested for this underuti-
lization including level of training, fear of complications or a percep-
tion of low yield. This study evaluated the efﬁcacy of transbronchial 
needle aspirations (TBNA) in a large academic center. The procedures 
were done by several endoscopists with varying levels of experience 
from novice to advanced. 
Methods: Records were retrospectively reviewed of all patients that 
had mediastinal sampling using TBNA at the Mayo Clinic, Rochester 
from January 2004 to December 2006. Sensitivity, speciﬁcity and diag-
nostic accuracy of TBNA was calculated for those patients with known 
or suspected lung cancer and mediastinal or hilar adenopathy. 
Results: Four hundred twenty-eights patients, with known or sus-
pected lung cancer and mediastinal lymphadenopathy, had TBNA (180 
females, 248 males, ages 32-95). The sensitivity of TBNA was 60.9%, 
speciﬁcity was 100.0%, and diagnostic accuracy was 65.7%. The 
sensitivity and diagnostic accuracy of station 7 was 63.3% and 69.8% 
respectively. The sensitivity and diagnostic accuracy for station 4R, 4L, 
≥10R and ≥10L were as follows: 59.1% and 64.9%, 60.5% and 68.8%, 
58.0% and 61.8%, and 51.9% and 62.9%. No complications were 
identiﬁed. 
Conclusion: TBNA is effective in determining malignant involvement 
of mediastinum even in a teaching institution with both experienced 
and novice endoscopists. Among the invasive staging modalities, 
TBNA should be considered as one of ﬁrst the procedures for sampling 
mediastinal lymph nodes. 
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Introduction: The incidence of malignant pleural mesothelioma 
(MPM) is increasing. Mediastinal nodal metastasis is usually associated 
with poor outcome after therapy the incidence and pattern of lymph 
node metastases are not well understood.
The aim of this study s to evaluate the prevalence and pattern of lymph 
node metastasis in MPM.
Patients and Methods: A total of 53 patients with pathologically 
proven malignant pleural mesothelioma were included in a study be-
tween January 2002 - December 2006.
The ﬁrst 37 (group I) patients underwent combined modality treat-
ment including primary surgery followed by chemo-radiotherapy, in 
this group no mediastinoscopy was done. The second group included 
16 patients with pre-treatment mediastinoscopy. Patients with negative 
mediastinoscopy were included in a tri modality treatment protocol, 
while those with positive mediastinoscopy, were excluded from this 
protocol.
Results: Among the studied patients, there were 33 males and 20 fe-
males. Right side was affected in 34 patients, the remaining 19 patients 
had left sided lesions, the mean age of the patients was 34 years. A total 
of 18 (34%) patients had positive lymph nodes. In group I, 12 patients 
had positive mediastinal lymph nodes of them only 2 had mediastinal 
lymphadenopathy on pre-operative CT. 
In group II, 4 patients had positive mediastinoscopy and 2 more had 
positive mediastinal nodes on ﬁnal pathology out of reach of mediasti-
noscopy.
Post-operatively, lymph nodes size ranged between 0.3X0.3cm- 
2X2.5cm and the number of nodes dissected was between 5-34 with a 
mean of 14 nodes. 
Post pleuropneumonectomy, 6 patients out of 14 had positive hilar 
lymph node metastases in addition to positive mediastinal lymph nodes. 
There was one patient with N1 disease only.
Of the 49 patients that had undergone surgery, only 7 patients had no 
lung invasion by pathologic evaluation, non of them had positive hilar 
nodes. The mechanism of spread of the disease to hilar lymph nodes 
may be through lung invasion ﬁrst and not a direct spread of the disease 
from the pleura. This observation rise the possibility that mediastinal 
lymph nodes are considered the primary station in patients with MPM 
and hilar lymph node metastasis necessitate lung invasion ﬁrst. Ma-
lignant pleural mesothelioma may also have unusual pattern of nodal 
metastases as we had 2 patients with positive para esophageal and an 
other 2 patients with positive diaphragmatic node within the group with 
mediastinal nodal metastases.
Mediastinal nodal metastases carries a dismal prognosis as no single 
patient with positive mediastinal nodes survived 3 years after tri modal-
ity treatment. 
